查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946499

施马伦贝格病毒治疗市场 - 全球产业规模、份额、趋势、机会及预测（按治疗类型、动物类型、地区和竞争格局划分，2021-2031年）

Schmallenberg Virus Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Animal Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球施马伦贝格病毒治疗市场预计将从 2025 年的 1.4767 亿美元成长到 2031 年的 2.3485 亿美元，复合年增长率为 8.04%。

该市场领域涵盖兽医干预措施，包括疫苗接种、诊断设备和支持性护理，旨在减轻正布尼亚病毒对反刍家畜的有害影响。推动该市场成长的主要因素是迫切需要避免因牛出生缺陷和死胎造成的严重经济损失。此外，人们对动物福利的日益关注以及在流行地区实施综合畜牧健康策略的需求，也持续推动对有效应对措施的需求。

市场概览
预测期 2027-2031
市场规模：2025年 1.4767亿美元
市场规模：2031年 2.3485亿美元
复合年增长率：2026-2031年 8.04%
成长最快的细分市场 支持性护理
最大的市场 北美洲

高额损失凸显了该市场的紧迫性：2024年，国家绵羊委员会报告称，在受灾严重的地区，早期产羔羊群的羔羊损失率高达10%至25%，这凸显了可靠管理解决方案的必要性。儘管需求强劲，但由于病毒爆发的间歇性和週期性，市场成长面临许多障碍。这种不可预测性导致收入来源不稳定，并使药物研发者的长期生产计画变得复杂，往往阻碍了对新治疗方法研发的持续投资。

市场驱动因素

施马伦贝格病毒在牲畜中的发生率不断上升，是推动市场扩张的主要因素，也因此对诊断和管理资源的需求即时。由于病毒呈现週期性復发，先天性畸形和死胎的突然增加，使得兽医必须迅速采取行动，控制病毒传播，维护畜群健康。根据AgriLand 2025年2月的报告，2024年爱尔兰确诊病例数较去年激增2,200%。这一快速增长凸显了该疾病的变异性，以及在感染高峰期提供及时治疗方案的重要性。该病原体对多种反刍动物的影响也显而易见，《爱尔兰农民日誌》报道称，2025年有12个牛的检测结果呈阳性。

此外，为最大限度减少生产损失，生产者不得不投资有效的治疗和支持性护理措施。难产、兽医服务以及可售牲畜损失所带来的成本，促使农民实施严格的卫生通讯协定以保障利润。一项发表于2025年8月《兽医檔案》的研究，聚焦于2023-2024年英国羔羊产季，发现44个受感染的农场在财务稳定性和羊群福利方面受到的负面影响显着大于未受影响的农场。这些财务压力迫使生产者采取强化监测和应对策略，而减轻对农场盈利的损害对于维持受影响地区的反刍动物生产系统至关重要。

市场挑战

全球施马伦贝格病毒治疗市场的扩张受到其零星且週期性爆发模式的显着阻碍。与需要定期年度治疗的疾病不同，这种正布尼亚病毒的传播率受媒介活动和群体免疫的影响，呈现不稳定的波动性，导致需求激增期与长期市场停滞期交替出现。这种不可预测性使得製药公司难以预测收入，也难以合理安排研发和生产新疗法所需的大量资本投入。

因此，相关人员在库存管理方面面临重大风险，经常在需求高峰期出现缺货，而在需求低迷期则造成产品浪费。英国全国农民联盟的一份报告凸显了这种波动性，该报告指出，2024年初，病毒在英国畜牧业突然捲土重来，短短六週内就确诊了63例病例，这表明典型的疫情爆发週期为三到五年。这种波动性阻碍了先进医疗解决方案的长期研发，因为企业往往更倾向于稳定的市场而非週期性市场。

市场趋势

快速现场诊断试剂盒正日益普及，为畜牧生产者提供便利，避免了集中检测固有的物流延误。如果没有即时的现场确认，农民在零星疫情爆发期间将面临不确定性，这不仅阻碍了受感染动物的快速隔离，也使畜群管理变得更加复杂。现有检测设施日益增长的压力凸显了这个问题。根据 Agriland 2025 年 2 月报道，在 2024 年的监测期内，爱尔兰农业、林业和渔业部 (DAFM) 不得不分析 369牛和 84 隻羊的检体，以确认病毒的存在。这种对外部检测的严重依赖正在推动市场对即时的现场病原体检测工具的需求，从而缩短从怀疑到应对的时间。

同时，施马伦贝格病毒与其他蠓虫传播疾病（例如蓝探戈病毒）的地理分布重迭，推动了多价疫苗和联合疫苗的快速研发。製药公司正优先开发频谱疫苗製剂，以提供双重保护，从而有效降低反刍动物群接种不同疫苗的工作量和成本。多种病毒同时威胁的规模凸显了市场对这类综合解决方案的需求。根据爱尔兰农业食品发展局（Teagasc）2025年1月发布的最新数据，2024年荷兰超过1万个地点被检测出蓝探戈病毒呈阳性，这凸显了采取联合预防策略以应对欧洲各地通用虫媒传播疾病问题的必要性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5.全球Schmallenberg病毒治疗市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依治疗类型（支持性治疗、病媒控制、预防措施）
    • 依动物种类（牛、羊、山羊）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美施马伦贝格病毒治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲施马伦贝格病毒治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区施马伦贝格病毒治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东与非洲施马伦贝格病毒治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲施马伦贝格病毒治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第 13 章：全球 Schmallenberg 病毒治疗市场：SWOT 分析

第十四章 波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Boehringer Ingelheim International GmbH
  • Zoetis
  • MSD Animal Health
  • Elanco Animal Health
  • Neogen Corporation
  • Heska Corporation
  • Phibro Animal Health
  • IDT Biologika
  • Phibro Animal Health
  • Dechra Pharmaceuticals

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19886

The Global Schmallenberg Virus Treatment Market is projected to expand from USD 147.67 Million in 2025 to USD 234.85 Million by 2031, registering a CAGR of 8.04%. This market sector comprises veterinary interventions, including preventive vaccinations, diagnostic instruments, and supportive care therapies aimed at reducing the Orthobunyavirus's detrimental effects on ruminant livestock. Growth is primarily propelled by the critical necessity to avert severe financial setbacks caused by congenital defects and stillbirths within cattle and sheep populations. Furthermore, the rising emphasis on animal welfare and the requirement for comprehensive herd health strategies in endemic areas continue to drive the demand for efficient control measures.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 147.67 Million
Market Size 2031USD 234.85 Million
CAGR 2026-20318.04%
Fastest Growing SegmentSupportive Care
Largest MarketNorth America

High-impact losses underscore the urgency of this market; the National Sheep Association noted in 2024 that early lambing flocks in hard-hit regions suffered lamb losses ranging from 10% to 25%, emphasizing the need for dependable management solutions. Despite this strong demand, market growth faces a significant hurdle due to the sporadic and cyclical nature of viral outbreaks. This unpredictability creates unstable revenue streams and complicates long-term production planning for pharmaceutical developers, often discouraging sustained investment in the creation of new therapeutic options.

Market Driver

The rising frequency of Schmallenberg virus outbreaks in livestock serves as a major engine for market expansion, generating an immediate need for diagnostic and management resources. As the virus returns in cyclical waves, the sudden spike in congenital malformations and stillbirths requires prompt veterinary action to limit transmission and maintain herd health. According to an Agriland report from February 2025, the number of confirmed cases in Ireland surged by 2,200% in 2024 compared to the previous year. This sharp increase highlights the disease's volatility and the vital importance of having treatment options readily available during infection peaks, while the pathogen's impact on various ruminants is evidenced by the Irish Farmers Journal reporting 12 cattle herds testing positive in 2025.

Moreover, the economic necessity of minimizing production losses pushes producers to fund effective treatment and supportive care measures. The costs associated with difficult births, veterinary services, and the loss of marketable offspring compel farm managers to implement strict health protocols to safeguard their profits. A study published in the Veterinary Record in August 2025, focusing on the 2023-2024 UK lambing season, revealed that 44 farms with confirmed infections faced considerably greater negative impacts on financial stability and flock welfare than unaffected farms. These financial strains necessitate the use of thorough surveillance and response strategies, as reducing the damage to farm profitability is crucial for maintaining ruminant production systems in affected regions.

Market Challenge

The expansion of the Global Schmallenberg Virus Treatment Market is significantly hindered by the sporadic and cyclical pattern of outbreaks. Unlike diseases that demand regular, annual treatments, this Orthobunyavirus demonstrates a volatile transmission rate influenced by vector activity and herd immunity, resulting in phases of intense demand followed by long periods of market inactivity. This unpredictability makes it extremely difficult for pharmaceutical manufacturers to predict revenue or rationalize the heavy capital investment needed for researching and producing new therapeutics.

As a result, stakeholders encounter major risks regarding inventory control, frequently facing stock shortages during spikes or product wastage during quiet periods. This instability is highlighted by the National Farmers Union, which reported a sudden viral resurgence in the UK livestock sector in early 2024, with 63 confirmed cases occurring over just six weeks, indicative of the typical three-to-five-year outbreak cycle. Such erratic fluctuations discourage long-term commitment to developing advanced medical solutions, as companies tend to favor stable markets over those characterized by boom-and-bust cycles.

Market Trends

There is a growing trend toward adopting rapid point-of-care diagnostic kits as livestock producers look to avoid the logistical delays inherent in centralized reference laboratories. Without immediate on-site confirmation, farmers deal with uncertainty during sporadic outbreaks, which impedes the quick isolation of infected animals and complicates herd management. The strain on existing testing facilities highlights this issue; as noted by Agriland in February 2025, the Department of Agriculture, Food and the Marine (DAFM) had to analyze 369 cattle and 84 sheep samples to confirm the virus's presence during the 2024 surveillance period. This heavy reliance on off-site testing is driving the market toward field-ready tools capable of real-time pathogen detection, thereby shortening the time between suspicion and action.

Concurrently, the development of multivalent and combination vaccines is being fast-tracked due to the overlapping geographic presence of the Schmallenberg virus and other midge-borne diseases like Bluetongue. Pharmaceutical developers are increasingly prioritizing broad-spectrum formulations to offer dual protection, effectively lowering the labor and costs involved in administering separate vaccines to ruminant herds. The market's need for such integrated solutions is emphasized by the magnitude of simultaneous viral threats; according to a Teagasc update in January 2025, the Netherlands reported over 10,000 Bluetongue-positive locations in 2024, presenting a strong argument for combined prophylactic strategies to tackle the shared vector challenge across European regions.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Zoetis
  • MSD Animal Health
  • Elanco Animal Health
  • Neogen Corporation
  • Heska Corporation
  • Phibro Animal Health
  • IDT Biologika
  • Phibro Animal Health
  • Dechra Pharmaceuticals

Report Scope

In this report, the Global Schmallenberg Virus Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Schmallenberg Virus Treatment Market, By Treatment Type

  • Supportive Care
  • Vector Control
  • Preventive Measures

Schmallenberg Virus Treatment Market, By Animal Type

  • Cattle
  • Sheep
  • Goats

Schmallenberg Virus Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Schmallenberg Virus Treatment Market.

Available Customizations:

Global Schmallenberg Virus Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Schmallenberg Virus Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment Type (Supportive Care, Vector Control, Preventive Measures)
    • 5.2.2. By Animal Type (Cattle, Sheep, Goats)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Schmallenberg Virus Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment Type
    • 6.2.2. By Animal Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Schmallenberg Virus Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment Type
        • 6.3.1.2.2. By Animal Type
    • 6.3.2. Canada Schmallenberg Virus Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment Type
        • 6.3.2.2.2. By Animal Type
    • 6.3.3. Mexico Schmallenberg Virus Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment Type
        • 6.3.3.2.2. By Animal Type

7. Europe Schmallenberg Virus Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment Type
    • 7.2.2. By Animal Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Schmallenberg Virus Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment Type
        • 7.3.1.2.2. By Animal Type
    • 7.3.2. France Schmallenberg Virus Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment Type
        • 7.3.2.2.2. By Animal Type
    • 7.3.3. United Kingdom Schmallenberg Virus Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment Type
        • 7.3.3.2.2. By Animal Type
    • 7.3.4. Italy Schmallenberg Virus Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment Type
        • 7.3.4.2.2. By Animal Type
    • 7.3.5. Spain Schmallenberg Virus Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment Type
        • 7.3.5.2.2. By Animal Type

8. Asia Pacific Schmallenberg Virus Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment Type
    • 8.2.2. By Animal Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Schmallenberg Virus Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment Type
        • 8.3.1.2.2. By Animal Type
    • 8.3.2. India Schmallenberg Virus Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment Type
        • 8.3.2.2.2. By Animal Type
    • 8.3.3. Japan Schmallenberg Virus Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment Type
        • 8.3.3.2.2. By Animal Type
    • 8.3.4. South Korea Schmallenberg Virus Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment Type
        • 8.3.4.2.2. By Animal Type
    • 8.3.5. Australia Schmallenberg Virus Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment Type
        • 8.3.5.2.2. By Animal Type

9. Middle East & Africa Schmallenberg Virus Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment Type
    • 9.2.2. By Animal Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Schmallenberg Virus Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment Type
        • 9.3.1.2.2. By Animal Type
    • 9.3.2. UAE Schmallenberg Virus Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment Type
        • 9.3.2.2.2. By Animal Type
    • 9.3.3. South Africa Schmallenberg Virus Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment Type
        • 9.3.3.2.2. By Animal Type

10. South America Schmallenberg Virus Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment Type
    • 10.2.2. By Animal Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Schmallenberg Virus Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment Type
        • 10.3.1.2.2. By Animal Type
    • 10.3.2. Colombia Schmallenberg Virus Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment Type
        • 10.3.2.2.2. By Animal Type
    • 10.3.3. Argentina Schmallenberg Virus Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment Type
        • 10.3.3.2.2. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Schmallenberg Virus Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zoetis
  • 15.3. MSD Animal Health
  • 15.4. Elanco Animal Health
  • 15.5. Neogen Corporation
  • 15.6. Heska Corporation
  • 15.7. Phibro Animal Health
  • 15.8. IDT Biologika
  • 15.9. Phibro Animal Health
  • 15.10. Dechra Pharmaceuticals

16. Strategic Recommendations

17. About Us & Disclaimer